MarketPulse

pharmacokinetics

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Tonix Pharmaceuticals

Tonix's TONMYA Shows Strong Pharmacokinetics Data as First New Fibromyalgia Treatment in 15 Years Gains Traction

Tonix Pharmaceuticals publishes peer-reviewed pharmacokinetic data for TONMYA, the first new fibromyalgia treatment in 15 years, showing rapid absorption and superior bioavailability.
TNXPFDA approvalclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Septerna's SEP-631 Shows Promise in Mast Cell Disease Treatment

Septerna reports positive Phase 1 data for SEP-631, an experimental oral treatment for mast cell-driven diseases, with plans for Phase 2b development beginning late 2026.
SEPNchronic spontaneous urticariaoral small-molecule